<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02952612</url>
  </required_header>
  <id_info>
    <org_study_id>KC16OISI0414</org_study_id>
    <nct_id>NCT02952612</nct_id>
  </id_info>
  <brief_title>Active Surveillance of Papillary Thyroid Microcarcinoma</brief_title>
  <official_title>Active Surveillance of Papillary Thyroid Microcarcinoma (PTMC) in Catholic Medical Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dong Jun Lim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul St. Mary's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Papillary thyroid microcarcinoma are small thyroid cancer measuring 1cm or less. Most of this
      tumor are not palpable and are identified either through pathologic examination or from
      imaging modalities, such as CT scan or thyroid sono. Active surveillance of papillary
      microcarcinoma is to observe thyroid papillary cancer without immediate surgical approach.
      The purpose of this study is to understand more about the characteristics of papillary
      microcarcinoma, which has been known for &quot;the cancer slowly progression&quot;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Progression of papillary thyroid microcarcinoma</measure>
    <time_frame>5 years after enrollment</time_frame>
    <description>Using thyroid sonography, check any changes in size and shape of papillary thyroid microcarcinoma</description>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Thyroid Cancer, Papillary</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This observational study enrolls patients who was diagnosed as papillary thyroid
        microcarcinoma by FNA (Fine needle aspiration) or CNA(Core needle aspiration) and who wish
        to be enrolled this study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. &lt; 1 cm solitary nodule

          2. Surrounded by ≥ 2 mm normal thyroid parenchyma

          3. Subcapsular locations not adjacent to surrounding structures, recurrent laryngeal
             nerve, trachea, or carotid artery

          4. No evidence of invasion to surrounding structures, recurrent laryngeal nerve, trachea
             or carotid artery

          5. No extrathyroidal extension

          6. Clinically N0 and Clinically M0

          7. ≥ 18 years

          8. Combined severe comorbidities or Inoperable condition (optional)

          9. No wish to surgery and Willingness to accept active surveillance

         10. No history of radiotherapy on head and neck area

         11. Accepted by the Board of Thyroid Cancer Meeting

        Exclusion Criteria:

          1. ≥ 1 cm nodule and multifocal nodules regardless of size

          2. Papillary thyroid carcinoma variants associated with poor prognosis (tall cell
             variant, columnar variant, hobnail variant) or other types of thyroid cancer)

          3. Subcapsular locations adjacent to surrounding structures, recurrent laryngeal nerve,
             trachea or carotid artery

          4. Evidence of invasion to surrounding structures, recurrent laryngeal nerve, trachea or
             carotid artery

          5. Extrathyroidal extension

          6. Any of N1 or M1

          7. Documented increase in size according to America Thyroid Association (ATA) guideline
             in a previously confirmed Papillary thyroid microcarcinoma

          8. &lt; 18 years

          9. Not willing to accept observational active surveillance approach
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dong-Jun Lim, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Seoul St. Mary's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeonghoon Ha, MD</last_name>
    <phone>+82-2-2258-6372</phone>
    <email>hajhoon@catholic.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kwanhoon Jo, MD</last_name>
    <phone>+82-2-2258-1220</phone>
    <email>lovi@naver.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul St Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Seocho-Gu</state>
        <zip>137-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong Jun Lim, MD,PhD</last_name>
      <phone>+82-2-2258-1220</phone>
      <email>ldj6026@catholic.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Kwanhoon Jo, MD</last_name>
      <phone>82-2-2258-1220</phone>
      <email>lovi@naver.com</email>
    </contact_backup>
    <investigator>
      <last_name>Jeonghoon Ha, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kwanhoon Jo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeongmin Lee, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2016</study_first_submitted>
  <study_first_submitted_qc>October 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2016</study_first_posted>
  <last_update_submitted>November 5, 2016</last_update_submitted>
  <last_update_submitted_qc>November 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Seoul St. Mary's Hospital</investigator_affiliation>
    <investigator_full_name>Dong Jun Lim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Thyroid Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Papillary</mesh_term>
    <mesh_term>Carcinoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

